Logo image of ICOP.MI

ICOP SPA (ICOP.MI) Stock Fundamental Analysis

BIT:ICOP - Euronext Milan - IT0001214433 - Common Stock - Currency: EUR

13.85  0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ICOP. ICOP was compared to 41 industry peers in the Construction & Engineering industry. ICOP has an average financial health and profitability rating. ICOP is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

ICOP had positive earnings in the past year.
In the past year ICOP had a positive cash flow from operations.
ICOP.MI Yearly Net Income VS EBIT VS OCF VS FCFICOP.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

With a Return On Assets value of 4.54%, ICOP perfoms like the industry average, outperforming 56.82% of the companies in the same industry.
ICOP has a better Return On Equity (21.62%) than 72.73% of its industry peers.
ICOP has a better Return On Invested Capital (12.13%) than 63.64% of its industry peers.
ICOP had an Average Return On Invested Capital over the past 3 years of 9.56%. This is in line with the industry average of 10.70%.
The 3 year average ROIC (9.56%) for ICOP is below the current ROIC(12.13%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.54%
ROE 21.62%
ROIC 12.13%
ROA(3y)3.57%
ROA(5y)N/A
ROE(3y)14.08%
ROE(5y)N/A
ROIC(3y)9.56%
ROIC(5y)N/A
ICOP.MI Yearly ROA, ROE, ROICICOP.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 8.37%, ICOP belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
ICOP's Profit Margin has improved in the last couple of years.
ICOP has a better Operating Margin (10.32%) than 72.73% of its industry peers.
ICOP's Operating Margin has improved in the last couple of years.
ICOP has a Gross Margin of 32.39%. This is in the lower half of the industry: ICOP underperforms 63.64% of its industry peers.
Industry RankSector Rank
OM 10.32%
PM (TTM) 8.37%
GM 32.39%
OM growth 3Y324.53%
OM growth 5YN/A
PM growth 3Y75.7%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICOP.MI Yearly Profit, Operating, Gross MarginsICOP.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICOP is still creating some value.
The number of shares outstanding for ICOP has been increased compared to 1 year ago.
ICOP has a better debt/assets ratio than last year.
ICOP.MI Yearly Shares OutstandingICOP.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
ICOP.MI Yearly Total Debt VS Total AssetsICOP.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ICOP has an Altman-Z score of 2.27. This is not the best score and indicates that ICOP is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.27, ICOP is doing good in the industry, outperforming 61.36% of the companies in the same industry.
ICOP has a debt to FCF ratio of 2.52. This is a good value and a sign of high solvency as ICOP would need 2.52 years to pay back of all of its debts.
The Debt to FCF ratio of ICOP (2.52) is better than 70.45% of its industry peers.
ICOP has a Debt/Equity ratio of 0.66. This is a neutral value indicating ICOP is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.66, ICOP is in line with its industry, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 2.52
Altman-Z 2.27
ROIC/WACC1.58
WACC7.66%
ICOP.MI Yearly LT Debt VS Equity VS FCFICOP.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

ICOP has a Current Ratio of 1.21. This is a normal value and indicates that ICOP is financially healthy and should not expect problems in meeting its short term obligations.
ICOP has a Current ratio (1.21) which is in line with its industry peers.
ICOP has a Quick Ratio of 1.21. This is a bad value and indicates that ICOP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.91, ICOP is in line with its industry, outperforming 43.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.91
ICOP.MI Yearly Current Assets VS Current LiabilitesICOP.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 392.69% over the past year.
The Earnings Per Share has been growing by 76.67% on average over the past years. This is a very strong growth
ICOP shows a small growth in Revenue. In the last year, the Revenue has grown by 2.51%.
Measured over the past years, ICOP shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)392.69%
EPS 3Y76.67%
EPS 5YN/A
EPS Q2Q%400.61%
Revenue 1Y (TTM)2.51%
Revenue growth 3Y0.56%
Revenue growth 5YN/A
Sales Q2Q%-5.98%

3.2 Future

The Earnings Per Share is expected to grow by 31.07% on average over the next years. This is a very strong growth
ICOP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 42.21% yearly.
EPS Next Y54.97%
EPS Next 2Y40.95%
EPS Next 3Y31.07%
EPS Next 5YN/A
Revenue Next Year135.04%
Revenue Next 2Y65.52%
Revenue Next 3Y42.21%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICOP.MI Yearly Revenue VS EstimatesICOP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
ICOP.MI Yearly EPS VS EstimatesICOP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.05, the valuation of ICOP can be described as correct.
ICOP's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.98. ICOP is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 11.61, the valuation of ICOP can be described as very reasonable.
ICOP's Price/Forward Earnings is on the same level as the industry average.
ICOP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 15.05
Fwd PE 11.61
ICOP.MI Price Earnings VS Forward Price EarningsICOP.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

75.00% of the companies in the same industry are cheaper than ICOP, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICOP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.52
EV/EBITDA 19.17
ICOP.MI Per share dataICOP.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ICOP's earnings are expected to grow with 31.07% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y40.95%
EPS Next 3Y31.07%

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.47%, ICOP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.78, ICOP is paying slightly less dividend.
With a Dividend Yield of 0.47, ICOP pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.47%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y40.95%
EPS Next 3Y31.07%
ICOP.MI Yearly Income VS Free CF VS DividendICOP.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 5M 10M 15M

More info and screens

ICOP SPA

BIT:ICOP (6/23/2025, 7:00:00 PM)

13.85

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap382.68M
Analysts87.5
Price Target15.56 (12.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.47%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.22%
PT rev (3m)30.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)21.66%
Valuation
Industry RankSector Rank
PE 15.05
Fwd PE 11.61
P/S 3.02
P/FCF 14.52
P/OCF 8.26
P/B 7.8
P/tB 7.92
EV/EBITDA 19.17
EPS(TTM)0.92
EY6.64%
EPS(NY)1.19
Fwd EY8.62%
FCF(TTM)0.95
FCFY6.89%
OCF(TTM)1.68
OCFY12.11%
SpS4.58
BVpS1.77
TBVpS1.75
PEG (NY)0.27
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 21.62%
ROCE 14.72%
ROIC 12.13%
ROICexc 17.12%
ROICexgc 17.32%
OM 10.32%
PM (TTM) 8.37%
GM 32.39%
FCFM 20.81%
ROA(3y)3.57%
ROA(5y)N/A
ROE(3y)14.08%
ROE(5y)N/A
ROIC(3y)9.56%
ROIC(5y)N/A
ROICexc(3y)19.65%
ROICexc(5y)N/A
ROICexgc(3y)20.73%
ROICexgc(5y)N/A
ROCE(3y)11.6%
ROCE(5y)N/A
ROICexcg growth 3Y343.69%
ROICexcg growth 5YN/A
ROICexc growth 3Y335.34%
ROICexc growth 5YN/A
OM growth 3Y324.53%
OM growth 5YN/A
PM growth 3Y75.7%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 2.52
Debt/EBITDA 1.48
Cap/Depr 222.02%
Cap/Sales 15.78%
Interest Coverage 250
Cash Conversion 209.95%
Profit Quality 248.58%
Current Ratio 1.21
Quick Ratio 0.91
Altman-Z 2.27
F-Score5
WACC7.66%
ROIC/WACC1.58
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)392.69%
EPS 3Y76.67%
EPS 5YN/A
EPS Q2Q%400.61%
EPS Next Y54.97%
EPS Next 2Y40.95%
EPS Next 3Y31.07%
EPS Next 5YN/A
Revenue 1Y (TTM)2.51%
Revenue growth 3Y0.56%
Revenue growth 5YN/A
Sales Q2Q%-5.98%
Revenue Next Year135.04%
Revenue Next 2Y65.52%
Revenue Next 3Y42.21%
Revenue Next 5YN/A
EBIT growth 1Y877.66%
EBIT growth 3Y326.9%
EBIT growth 5YN/A
EBIT Next Year148.28%
EBIT Next 3Y46.4%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A